Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of FP versus FLP in metastatic gastric, pancreatic, and oesophageal cancer
ISRCTN05842222Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Apr 1995
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fluorouracil, cisplatin and folinic acid in gastric cancer (GC), pancreatic cancer (PC) and esophageal cancer (2 arms), sponsored by Fédération Francophone de Cancérologie Digestive. Primary endpoint: Safety. Started Apr 1995; status: completed.
02
Drugs
fluorouracilcisplatinfolinic acid
03
Conditions
gastric cancer (GC)pancreatic cancer (PC)esophageal cancer
Beyond the preview
Go deeper on ISRCTN05842222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN05842222.